Trial reportEuropean journal of applied physiology2026
Effect of ischemic preconditioning on microvascular post-occlusive hyperemic reactions and quadriceps morphology in MMA: a randomized clinical trial.
Trial report in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Overview of Ischemic Preconditioning as a Potential Therapeutic Target for Chronic Muscle Pain.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe purpose of this study was to compare the effects of a 14-day daily ischemic preconditioning (IPC) intervention versus a sham IPC intervention on microvascular post-occlusive hyperemic reactions and quadriceps muscle morphology in martial arts athletes.
designThis randomized controlled trial involved 28 adults specializing in martial arts, who were randomly assigned to either the IPC or sham IPC group.
methodsParticipants in the IPC intervention completed two daily sessions over 14 consecutive days. Each session consisted of three cycles of 5 min of 100% arterial occlusion pressure (AOP) followed by 5 min of rest, for a total session duration of 30 min. Assessments were conducted at baseline, immediately after the 14-day intervention (afterInt), 7 days post-intervention (7d-afterInt), and 2 weeks post-intervention (2w-afterInt). The measured outcomes included peak isometric strength, rate of force development (RFD), pennation angle at rest (PA rest) and during maximal contraction (PA contraction), resting blood flow (RF), minimum and 100% AOP, biological zero (BZ), reactive hyperemia (RH max), time to peak maximal perfusion (TP), recovery time for perfusion to return to resting values (TR).
resultsSignificantly higher RFD values in IPC afterInt (p = 0.005) as well as RF values (p = 0.014) were found. Significantly higher BZ values in IPC afterInt (p < 0.001) as well as 7d-afterInt (p < 0.001) were also found.
conclusionsThis study suggests that the significant positive effects of IPC, compared to shamIPC, on strength and perfusion parameters persist for up to 7 days after the intervention.
Indexed as
Identifiers
40721516What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.